Targeting Treg cells to mitigate inflammation has been a challenge, but a parasite-derived cytokine may be key to engineering a Treg cell therapy.
A parasite partner for regulatory affairs | Science Immunology
Targeting Treg cells to mitigate inflammation has been a challenge, but a parasite-derived cytokine may be key to engineering a Treg cell therapy.